Suspension of trading

Income Statement Forte Biosciences

Stocks

FBRX

US34962G2084

Market Closed - Nasdaq 04:00:00 27/08/2026 HKT			5-day change	1st Jan Change
76.99 ^USD	+0.03%		-.--%	+182.32%

08-31	Forte Biosciences, Inc.(NasdaqGM:FBRX) dropped from Russell 3000E Growth Index	CI
08-31	Forte Biosciences, Inc.(NasdaqGM:FBRX) dropped from Russell Microcap Growth Index	CI

4d242a54c2.qRucr6euUZccjXFdl2QjS3TZhzJhlmtCwjto147Qvv8.xHnD9vaDE6ZF2kEu-y4afRaY3kFM7kYgu2surf2V3ZfaRNXM3-EX5n_UFg

Published financial data: FORTE BIOSCIENCES

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Selling General & Admin Expenses, Total	7.63M	8.3M	10.62M	15.41M	12.41M
R&D Expenses	13.85M	5.59M	21.86M	21.19M	58.25M
Other Operating Expenses, Total	21.49M	13.9M	32.49M	36.6M	70.66M
Operating Income	-21.49M	-13.9M	-32.49M	-36.6M	-70.66M
Interest Expense, Total	-	-	-	-	-
Interest And Investment Income	-	-	1.12M	1.31M	2.72M
Net Interest Expenses	-	-	1.12M	1.31M	2.72M
Other Non Operating Income (Expenses)	-222K	17K	-114K	-190K	-396K
EBT, Excl. Unusual Items	-21.71M	-13.88M	-31.48M	-35.48M	-68.34M
In Process R&D Expenses	-	-	-	-	-
EBT, Incl. Unusual Items	-21.71M	-13.88M	-31.48M	-35.48M	-68.34M
Income Tax Expense	-	-	-	-	1.04M
Earnings From Continuing Operations	-21.71M	-13.88M	-31.48M	-35.48M	-69.38M
Net Income to Company	-21.71M	-13.88M	-31.48M	-35.48M	-69.38M
Net Income - (IS)	-21.71M	-13.88M	-31.48M	-35.48M	-69.38M
Net Income to Common Incl Extra Items	-21.71M	-13.88M	-31.48M	-35.48M	-69.38M
Net Income to Common Excl. Extra Items	-21.71M	-13.88M	-31.48M	-35.48M	-69.38M
Per Share Items
Net EPS - Basic	-38.85	-19.96	-24.92	-12.17	-4.71
Basic EPS - Continuing Operations	-38.85	-19.96	-24.92	-12.17	-4.71
Basic Weighted Average Shares Outstanding	559K	695K	1.26M	2.92M	14.72M
Net EPS - Diluted	-38.85	-20	-24.92	-12.17	-4.71
Diluted EPS - Continuing Operations	-38.85	-20	-24.92	-12.17	-4.71
Diluted Weighted Average Shares Outstanding	559K	695K	1.26M	2.92M	14.72M
Normalized Basic EPS	-24.28	-12.47	-15.58	-7.6	-2.9
Normalized Diluted EPS	-24.28	-12.47	-15.58	-7.6	-2.9
Supplemental Items
EBITDA	-21.45M	-13.86M	-32.48M	-36.56M	-70.59M
EBITA	-21.49M	-13.9M	-32.49M	-36.6M	-70.66M
EBIT	-21.49M	-13.9M	-32.49M	-36.6M	-70.66M
EBITDAR	-21.44M	-13.84M	-32.35M	-36.26M	-70.18M
Effective Tax Rate - (Ratio)	-	-	-	-	-1.52
Current Foreign Taxes	-	-	-	-	1.04M
Total Current Taxes	-	-	-	-	1.04M
Normalized Net Income	-13.57M	-8.67M	-19.67M	-22.17M	-42.71M
Supplemental Operating Expense Items
General and Administrative Expenses	7.63M	8.3M	10.62M	15.41M	12.41M
Research And Development Expense From Footnotes	13.85M	5.59M	21.86M	21.19M	58.25M
Net Rental Expense, Total	5K	19K	129K	300K	408K
Stock-Based Comp., R&D Exp. (Total)	1.45M	1.27M	1.2M	1.08M	1.71M
Stock-Based Comp., G&A Exp. (Total)	2.77M	2.74M	2.08M	2.02M	4.55M
Total Stock-Based Compensation	4.21M	4.02M	3.28M	3.1M	6.26M

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Assets
Cash And Equivalents	42.04M	41.1M	37.12M	22.24M	76.96M
Short Term Investments	-	-	-	36.12M	-
Total Cash And Short Term Investments	42.04M	41.1M	37.12M	58.36M	76.96M
Other Receivables	-	-	-	-	817K
Total Receivables	-	-	-	-	817K
Prepaid Expenses	388K	341K	1.04M	2.64M	2.39M
Other Current Assets, Total	88K	70K	165K	336K	422K
Total Current Assets	42.52M	41.51M	38.33M	61.35M	80.59M
Gross Property Plant And Equipment	-	-	118K	125K	241K
Accumulated Depreciation	-	-	-9K	-48K	-112K
Net Property Plant And Equipment	-	-	109K	77K	129K
Deferred Charges Long-Term	106K	-	-	-	-
Other Long-Term Assets, Total	680K	486K	544K	138K	2.06M
Total Assets	43.31M	42M	38.98M	61.56M	82.78M
Liabilities
Accounts Payable, Total	946K	1.15M	1.42M	4.88M	9.99M
Accrued Expenses, Total	812K	2.03M	2.24M	4.2M	9.84M
Other Current Liabilities	-	-	-	-	927K
Total Current Liabilities	1.76M	3.18M	3.67M	9.08M	20.75M
Other Non Current Liabilities	-	-	-	-	1.04M
Total Liabilities	1.76M	3.18M	3.67M	9.08M	21.79M
Preferred Stock Convertible	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	15K	21K	36K	6K	13K
Additional Paid In Capital	115M	126M	154M	206M	284M
Retained Earnings	-73.16M	-87.04M	-119M	-154M	-223M
Comprehensive Income and Other	-	-	4K	11K	3K
Total Common Equity	41.55M	38.82M	35.31M	52.48M	60.99M
Total Equity	41.55M	38.82M	35.31M	52.48M	60.99M
Total Liabilities And Equity	43.31M	42M	38.98M	61.56M	82.78M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	590K	840K	1.46M	6.58M	18.77M
ECS Total Common Shares Outstanding	590K	840K	1.45M	6.39M	17.83M
Book Value / Share	70.4	46.21	24.3	8.21	3.42
Tangible Book Value	41.55M	38.82M	35.31M	52.48M	60.99M
Tangible Book Value Per Share	70.4	46.21	24.3	8.21	3.42
Total Debt	0	0	0	0	0
Net Debt	-42.04M	-41.1M	-37.12M	-58.36M	-76.96M
Debt Equivalent Oper. Leases	40K	152K	1.03M	2.4M	3.26M
Account Code - Inventory Valuation	-	3	3	3	3
Machinery, Total	-	-	118K	125K	241K
Full Time Employees	5	6	9	14	19

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Net Income	-21.71M	-13.88M	-31.48M	-35.48M	-69.38M
Depreciation & Amortization - CF	36K	-	9K	39K	64K
Depreciation & Amortization, Total	36K	-	9K	39K	64K
(Gain) Loss on Sale of Investments - (CF)	-	-	-131K	-158K	-237K
Asset Writedown & Restructuring Costs	61K	-	-	-	-
Stock-Based Compensation (CF)	4.21M	4.02M	3.28M	3.1M	6.26M
Other Operating Activities, Total	-	-	-	-	-
Change In Accounts Payable	-294K	207K	271K	3.02M	5.54M
Change In Income Taxes	-	-	-	-	1.04M
Change in Other Net Operating Assets	1.01M	1.47M	-663K	-1.26M	5.83M
Cash from Operations	-16.68M	-8.18M	-28.71M	-30.74M	-50.88M
Capital Expenditure	-	-	-88K	-37K	-116K
Cash Acquisitions	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-	-	135K	-35.96M	36.35M
Cash from Investing	-	-	47K	-35.99M	36.23M
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Issuance of Common Stock	62K	7.24M	24.74M	53.01M	76.83M
Repurchase of Common Stock	-	-	-60K	-35K	-29K
Issuance of Preferred Stock	-	-	-	-	-
Other Financing Activities, Total	-106K	-	-	-1.12M	-7.44M
Cash from Financing	-44K	7.24M	24.68M	51.86M	69.36M
Net Change in Cash	-16.72M	-944K	-3.98M	-14.88M	54.71M
Supplemental Items
Levered Free Cash Flow	-9.02M	-3.18M	-17.4M	-16.14M	-26.94M
Unlevered Free Cash Flow	-9.02M	-3.18M	-17.4M	-16.14M	-26.94M
Change In Net Working Capital	-156K	-1.49M	304K	-3.64M	-11.02M
Net Debt Issued / Repaid	-	-	-	-	-

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Profitability
Return on Assets	-25.69	-20.36	-50.15	-45.51	-61.19
Return on Total Capital	-26.72	-21.61	-54.78	-52.11	-77.84
Return On Equity %	-43.19	-34.54	-84.92	-80.82	-122.28
Return on Common Equity	-43.19	-34.54	-84.92	-80.82	-122.28
Short Term Liquidity
Current Ratio	24.19	13.06	10.45	6.76	3.88
Quick Ratio	23.92	12.93	10.13	6.43	3.75
Operating Cash Flow to Current Liabilities	-9.49	-2.57	-7.83	-3.39	-2.45
Long Term Solvency
Total Liabilities / Total Assets	4.06	7.57	9.4	14.75	26.32
EBIT / Interest Expense	-	-	-	-	-
Net Debt / EBITDA	1.96	2.97	1.14	1.6	1.09
Net Debt / (EBITDA - Capex)	1.96	2.97	1.14	1.59	1.09
Growth Over Prior Year
EBITDA, 1 Yr. Growth %	51.37	-35.38	134.32	12.58	93.07
EBITA, 1 Yr. Growth %	51.04	-35.33	133.78	12.67	93.04
EBIT, 1 Yr. Growth %	51.04	-35.33	133.78	12.67	93.04
Earnings From Cont. Operations, 1 Yr. Growth %	-53.3	-36.07	126.79	12.71	95.54
Net Income, 1 Yr. Growth %	-53.3	-36.07	126.79	12.71	95.54
Normalized Net Income, 1 Yr. Growth %	50.44	-36.07	126.79	12.71	92.62
Diluted EPS Before Extra, 1 Yr. Growth %	-75.4	-48.52	24.87	-51.18	-61.26
Net Property, Plant and Equip., 1 Yr. Growth %	-	-	-	-29.36	67.53
Total Assets, 1 Yr. Growth %	-29.28	-3.02	-7.18	57.93	34.47
Tangible Book Value, 1 Yr. Growth %	-29.56	-6.57	-9.03	48.61	16.22
Common Equity, 1 Yr. Growth %	-29.56	-6.57	-9.03	48.61	16.22
Cash From Operations, 1 Yr. Growth %	-9.48	-50.92	250.71	7.1	65.5
Capital Expenditures, 1 Yr. Growth %	-	-	-	-57.95	213.51
Levered Free Cash Flow, 1 Yr. Growth %	11.4	-64.71	446.57	-7.24	66.85
Unlevered Free Cash Flow, 1 Yr. Growth %	11.4	-64.71	446.57	-7.24	66.85
Compound Annual Growth Rate Over Two Years
EBITDA, 2 Yr. CAGR %	130.05	-1.1	23.05	62.42	47.43
EBITA, 2 Yr. CAGR %	129.93	-1.16	22.96	62.3	47.48
EBIT, 2 Yr. CAGR %	129.93	-1.16	22.96	62.3	47.48
Earnings From Cont. Operations, 2 Yr. CAGR %	130.98	-45.36	20.41	59.88	48.46
Net Income, 2 Yr. CAGR %	130.98	-45.36	20.41	59.88	48.46
Normalized Net Income, 2 Yr. CAGR %	130.98	-1.93	20.41	59.88	47.35
Diluted EPS Before Extra, 2 Yr. CAGR %	-10.26	-64.41	-19.91	-21.92	-56.51
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-	-	-	8.79
Total Assets, 2 Yr. CAGR %	137.8	-17.19	-5.13	21.07	45.73
Tangible Book Value, 2 Yr. CAGR %	195.16	-18.87	-7.81	16.27	31.42
Common Equity, 2 Yr. CAGR %	195.16	-18.87	-7.81	16.27	31.42
Cash From Operations, 2 Yr. CAGR %	145.32	-33.35	31.2	93.81	33.14
Capital Expenditures, 2 Yr. CAGR %	-	-	-	-	14.81
Levered Free Cash Flow, 2 Yr. CAGR %	153.54	-37.3	38.88	125.17	24.41
Unlevered Free Cash Flow, 2 Yr. CAGR %	153.54	-37.3	38.88	125.17	24.41
Compound Annual Growth Rate Over Three Years
EBITDA, 3 Yr. CAGR %	-	50.66	31.84	19.46	72.05
EBITA, 3 Yr. CAGR %	214.87	50.65	31.69	19.43	71.96
EBIT, 3 Yr. CAGR %	214.87	50.65	31.69	19.43	71.96
Earnings From Cont. Operations, 3 Yr. CAGR %	193.15	50.53	-12.19	17.79	70.98
Net Income, 3 Yr. CAGR %	193.15	50.53	-12.19	17.79	70.98
Normalized Net Income, 3 Yr. CAGR %	193.15	50.53	29.69	17.79	70.12
Diluted EPS Before Extra, 3 Yr. CAGR %	152.82	-25.44	-45.96	-32.09	-38.19
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	3.96	-	-
Total Assets, 3 Yr. CAGR %	104.39	76.35	-13.98	12.44	25.38
Tangible Book Value, 3 Yr. CAGR %	283.45	101.16	-15.72	8.1	16.25
Common Equity, 3 Yr. CAGR %	283.45	101.16	-15.72	8.1	16.25
Cash From Operations, 3 Yr. CAGR %	199.93	43.48	15.93	22.62	83.87
Levered Free Cash Flow, 3 Yr. CAGR %	-	31.39	29.04	21.4	103.76
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	31.39	29.04	21.4	103.76
Compound Annual Growth Rate Over Five Years
EBITDA, 5 Yr. CAGR %	-	-	-	55.26	37.87
EBITA, 5 Yr. CAGR %	-	-	116.17	55.21	37.79
EBIT, 5 Yr. CAGR %	-	-	116.17	55.21	37.79
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	105.37	54.2	8.34
Net Income, 5 Yr. CAGR %	-	-	105.37	54.2	8.34
Normalized Net Income, 5 Yr. CAGR %	-	-	105.37	54.2	36.48
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	59.63	-24.08	-50.46
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	-12.72	5.87
Total Assets, 5 Yr. CAGR %	-	-	50.36	51.72	6.21
Tangible Book Value, 5 Yr. CAGR %	-	-	116.82	61.55	0.67
Common Equity, 5 Yr. CAGR %	-	-	116.82	61.55	0.67
Cash From Operations, 5 Yr. CAGR %	-	-	115.47	61.82	22.53
Capital Expenditures, 5 Yr. CAGR %	-	-	-	-25.57	-
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	62.99	27.17
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	62.99	27.17